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In thirty cases of resected primary gastric carcinoma, the relative 
utility of argyrophilic nucleolar organizer regions (AgNORs) staining 
(single staining) and sequential staining technique using proliferating 
cell nuclear antigen (PCNA) and AgNORs was studied. 
The mean number of AgNORs in PCNA-positive cells was 
significantly larger than that in AgNORs single stained cells. For 
above two groups, correrating mean number of AgNORs with 
clinicopathological factors revealed a significant difference between 
stage I + II and stage III + IV. In lymph node metastasis, the depth of 
invasion and size, only sequential stain-positive cells showed 
significant difference. 
On the other hand, only that of sequential stain-negative cells, a 
significant difference was found with regard to liver metastasis. 
As for other assessment, the ratio of AgNORs area per nuclear area 
was investigated using an image analyzer (IBAS 2000 KONTRON). 
Comparison of the ratio of AgNORs area per nuclear area between 
PCNA-positive cells and AgNORs single stained cells revealed a 
significant difference in regard to lymph node metastasis. On the 
other hand, between the ratio of AgNORs area per nuclear area in 
PCNA-negative cells and that of AgNORs single stained cells, a 
significant difference was found in regard to liver metastasis. 
Thus, the evaluation using PCNA for classifying cells into proliferating 
cells and nonproliferating cells in combination with AgNORs staining 
provided information of greater values to the malignancy assessment 
of gastric carcinoma as compared with the standard AgNORs single 
staining.
Introduction 
The malignancy assessment of carcinoma cells based on 
their proliferating potential using growth-related markers 
such as PCNA, Ki-67 and DNA polymerase a has been 
much studied in various organs by employing immunohis-
tochemical techniques. 
 Nucleolar organizer regions (NORs) are loops DNA in 
which ribosomal RNA (rRNA) is encoded. NOR-associated 
proteins and NORs themselves have been visualised re-
cently using the one-step silver staining (AgNORs) meth-
od. The silver staining technique identifies non-histone 
nuclear proteins associated with the sites of rRNA tran-
scription, with an increase in AgNORs number and area are 
said to reflect the proliferative activity of cells. Compared 
with normal cells, carcinoma cells have a higher prolif-
eration potential, and the higher the proportion of cells in 
proliferating phase, the poorer is the prognosis of the cases. 
It is, therefore, considerd that their staining methods are of 
great value for assessing the degree of malignancy in 
gastric carcinoma. 
 However, in order to evaluate all the biological behav-
iors of carcinoma cells, not only cells in proliferating phase 
but also cells in non-proliferating phase (resting cells) must 
be taken into consideration. This is because, in actual 
chemotherapy, non-proliferating cells are much refractory 
to treatment, and information on nonproliferating cells may 
be of great clinical value. From this point of view, the 
author stained proliferating cells with PCNA and, at the 
same time, AgNORs in both the proliferating population 
and the non-proliferating population, and evaluated the 
cytological characteristics of the cells in the respective 
population.
Materials and Methods 
Materials 
Samples of primary gastric carcinoma were available from 
30 patients who underwent gastrectomy at the First Depart-
ment of Surgery of Nagasaki University School of Medi-
cine. No patient had received chemotherapy before 
surgery. 
Methods 
A cube, Icm3, was cut out from the carcinoma lesion, fixed 
in 10% neutral buffered formalin for not more than 24 
hours and embedded in paraffin. Sections were cut at 3 ,u m 
thickness for use as specimens to be stained. The rationale 
of the above procedure was as follows. PCNA is variable in 
staining intensity and rate according to the fixation proce-
dure and time. When a paraffin block from a usual surgical 
specimen fixed for a prolonged time in 10% formalin is 
employed, immunostaining with PCNA may not neces-
sarily yield stable results but tends to give negative reac-
tion.41 The author also tentatively stained usual surgical
specimens fixed in 10% formalin in the conventional 
manner as well as specimens cut into lcm3 cubes and fixed 
in 10% neutral buffered formalin for less than 24 hours and 
discovered a remarkable difference between the two kinds 
of specimens in staining intensity and rete. Therefore, in 
the present study, the latter fixation procedure was fol-
lowed with satisfactory results. In sequential staining tech-
nique, PCNA was stained first, followed by AgNORs 
staining. 
1. Immunohistochemical staining with PCNA. 
As the primary antibody, PC 10 (DAKO), and anti-PCNA 
mouse monoclonal antibody, was used in 100-fold dilution 
for 60 minutes at room temperature. The staining was 
performed by the labelled streptavidine-biotin (LSAB) 
method using DAKO LSAB KIT, Alkaline Phosphatase. 
As the chromogen, Fast Red was used. 
2. AgNORs staining 
The PCNA stained preparation was washed thoroughly 
with distilled water (DW3) and AgNORs staining was 
carried out by the one-step silver staining method. The 
staining solution was prepared by dissolving powdered 
gelatin at a concentration of 2% (WN) in de-ionized water, 
pure fornic acid was then added to a final concentration of 
1%. This solution was mixed 1:2 volumes with 50% 
aqueous silver nitrate solution to give the working solution. 
The sections were incubated with the solution in the dark-
ness for 50 minutes. The AgNORs single staining was also 
carried out in the same menner except that reaction time 
was 25 minutes. To facilitate the determination of the 
number and sectional area of AgNORs, the silver was 
decolorized with 5% sodium thiosulfate in both procedures. 
Methods of assessment 
In each case, using a light microscope (Olympus VANOX) 
at a magnification of x1000, 100 carcinoma cells were 
observed and the mean numbers of AgNORs, granules per 
nucleus for each of AgNORs single stained carcinoma cells 
and PCNA-positive and PCNA-negative cells were calcu-
lated. 
  Furthermore, in each case, using an image analyzer 
(IBAS2000, Carl Zeiss), 100 carcinoma cells were scanned 
and the mean nuclear sectional area, AgNORs count, mean 
sectional area of AgNORs and the ratio of AgNORs per 
nuclear area were calculated for each of AgNORs single 
stained carcinoma cells and PCNA-positive and PCNA-
negative cells. A brief description of the image analyzer 
may be pertinent on this occasion. Once the area to be 
examined by microscopy is selected under a x1000 oilim-
mersion lens, the image is photographed with color CCD 
cameras connected to the barrel of the microscope and 
displayed on the cathode-ray tube and this live picture 
image is input to the image analyzer. Thereafter, the nuclei
are traced. For recognition of the whole nucleus, binari-
zation is performed at a comparatively low density. Then, 
for identification of NORs, binarization is carried out at 
high density. The above procedure is repeated for 100 
nuclei per specimen and the data are printed out. The data 
are tabulated as histograms. The statistical analysis of 
correlates of the data with clinicopathological factors and 
DNA ploidy was performed by the Wilcoxon test.
Results 
The breakdown of 30 gastric carcinoma cases is presented 
in Table 1. The criteria used were in conformity with the 
Gastric Cancer Staging System. In sequential staining tech-
nique, the PCNA labelling index (LI) was 46.3% and there 
was no correlation with clinicopathological factors and 
DNA ploidy. PCNA-positive cells included both strongly 
positive and weakly positive cells. In PCNA, staining, the 
nuclei were stained red and the intensity of stain was 
varying much. AgNORs were observed as small black dots 
and large irregularly-shaped black dots in the nucleus. A 
typical sequential staining technique case is shown in Fig. 
1.
Table 1. Pathologic profiles and DNA ploidy of the patients with 
gastric carcinoma
 No. of cases 30 
Macro 0 4 
                  1 2
                  2 7
                  3 10
                  4 5
                   5 2
Histologic type tub 1 5 
                   tub 2 10
                     por 15
Depth ps (-) 6 
                 ps (+) 24
stage I 5 
                 II 1 
                 III 12
                 IV 12 
DNA ploidy Diploid 10 
                  Aneuploid 20
Fig. 1. The sequential stain technique using PCNA and AgNORs.
1. Evaluation of AgNORs counts 
The mean AgNORs counts of PCNA-positive cells, PCNA-
negative cells and AgNORs single stained cells were 8.28 
± 1.45, 3.62 ± 0.67 and 5.76 ± 1.04, respectively. Thus, 
a significant difference (P < 0.0001) was found between 
PCNA-positive and -negative cells and between PCNA-
positive cells and AgNORs single stained cells (Table 2).
single staining, the mean AgNORs counts of PCNA-
positive cells showed a statistically significant difference 
between stage I + II and stage III + IV at a lower level of 
significance. In regard to lymph node metastasis, depth of 
invasion and size, only the mean AgNORs counts of 
PCNA-positive cells showed a significant difference. The 
mean AgNORs counts of PCNA-negative cells showed a 
significant difference in involvement of liver metastasis. 
With regard to DNA ploidy, aneuploid showed a tendency 
of increase as compared with diploid but there was no 
significant difference in any population (Table 3). 
2. Quantitative evaluation of AgNORs area. 
The mean AgNORs sectional area (,um') of normal cells, 
PCNA-positive and -negative carcinoma cells and AsNORs 
single stained carcinoma cells were 1.56 ± 0.48, 10.14 ± 
2.35, 4.08 ± 0.99 and 7.59 ± 2.34, respectively. There was 
significant differences among all populations (P < 0.0001) 
(Table 4).
Table 4. Mean AgNOR area for each cells groups (,u m2)
  PCNA positive cells 10.14 ± 2.35 
  PCNA negative cella 4.08 ± 0.99 •X 
  AgNORs single stained cells 7.59 ± 2.34 
(normal cells 1.56 ± 0.48) •X P < 0.0001
Table 2. Results (mean AgNOR counts)
  PCNA positive cells 8.28 ± 1.45 
  PCNA negative cells 3.62 ± 0.67 ~X X 
  AgNORs single stained cells 5.76 ± 1.04 
XP<0.0001
 The correlates with clinicopathological factors (accord-
ing to the Gastric Cancer Staging System) and DNA ploidy 
were studied. As to size, the mean value of 30 caces, viz. 
7.2cm, was used as the test. Compared with AgNORs
  In the sectional area of nuclei, too, normal cell and 
PCNA- positive and -negative cells and AgNORs single 
stained carcinoma cells were 28.13 ± 2.23, 78.15 ± 17.76, 
60.42 ± 13.2 and 67.56 ± 18.75, respectively. There were 
significant differnces among all population. (Table 5) 
Therefore, the sectional area of AgNORs relative to the 
sectional area of nuclei was investigated to find the ration 
of AgNORs area per nuclear area (%). 
 The ratio of AgNORs area per nuclear area (%) of
Table 3. Relationship between clinicopathologic factors and mean AgNOR counts
                         A B C 
        PS- 6.79 ± 1.72 5.09 ± 1.16 3.41 ± 0.81
       PS+ 8.65 ± 1.12 X X 5.92 ± 0.95 NS 3.67 ± 0.63 NS 
     stage I II 6.53 ± 1.30 4.86 ± 0.80 3.44 ± 0.84 
     stage 111 N 8.72 ± 1.12 X 5.98 ± 0.97 X X 3.66 ± 0.62 NS 
    size < 7.2cm 7.45 ± 1.46 5.33 ± 1.02 3.56 ± 0.64 
    size > 7.2cm 9.00 ± 0.99 X 6.12 ± 0.93 NS 3.67 ± 0.70 NS 
       n (-) 7.23 ± 1.57 5.14 ± 0.96 3.49 ± 0.68 NS 
       n (+) 8.73 ± 1.15 X X 6.01 ± 0.97 NS 3.67 ± 0.66 
        H - 8.20 ± 1.42 5.61 ± 0.86 3.45 ± 0.52 . 
       H + 8.65 ± 1.67 NS 6.48 ± 1.58 NS 4.42 ± 0.77 1 X X 
    Diploid 7.94+ 1.10 NS 5.38 ± 0.91 1 NS 3.45 ± 0.64 1 NS
     Aneuploid 8.45 ± 1.59 5.94 ± 1.06 3.70 ± 0.67 
A: PCNA positive cells •X P < 0 01 
B: AgNORs single stained cells X X P < 0.05 
C: PCNA negative cells NS: significant
Table 5. Mean nuclear area for each cells groups (,u m')
  PCNA positive cells 78.15 ± 17.76 
  PCNA negative cells 60.42 ± 13.20 X X 
  AgNORs single stained cells 67.56 ± 18.75 
(normal cells 28.13 ± 2.23) X P < 0.0001 X X P < 0.001
normal cells, PCNA-positive and -negative carcinoma cells 
and AgNORs single stained carcinoma cells were 5.73 ± 
1.54, 13.13 ± 2.20, 6.85 ± 1.47, 11.38 ± 2.26, respec-
tively, with a significant difference (P < 0.0001) among 
them (Table 6).
Table 6. The ratio of AgNORs area per nuclear area for each cells 
groups (%)
  PCNA positive cells 13.13 ± 2.20 -~~-~ 
  PCNA negative cells 6.85 ± 1.47 X 
  AgNORs single stained cells 11.38 ± 2.26 
(normal cells 5.73 ± 1.54) X P < 0.0001
 There results were evaluated in correlation with clinico-
pathological factors and DNA ploidy. As a result, only in 
lymph node metastasis, the ratio of AgNORs area per 
nuclear area (%) of PCNA-positive cells showed a signif-
icant differnce (P < 0.05) from that of AgNORs single 
stained cells. 
 In the assessment of PCNA-negative cells, a significant 
differnence (P < 0.01) was found in cases of liver metas-
tasis. There was no correlation with DNA ploidy in any 
population (Table 7).
Discussion 
The sequential staining technique of gastric carcinoma cells 
was carried out using AgNORs and PCNA. The AgNORs 
staining was originally developed by Howell et al in 19801'
and subsequently sophisticated by Ploton et al in 1986.2' 
Since then, with Crocker et al as leaders, the validity of the 
technique has been extensively explored, mainly in malig-
nant tumors, in various professional fields. In fact, because 
the resulting count, size and morphological information 
reflect the proliferation, differentiation and metabolism of 
cells, this staining technique has been utilized as a measure 
of malignancy. 
 PCNA, a growth-related marker, can be used for paraffin 
sections and have been employed broadly in retrospective 
studied, too. It is known that PCNA is a non-histon protein 
with a molecular weight of 36KD and that it is synthesised 
in the cell nucleus in the late G1 and S-phase of the cell 
cycle and functions as auxiliary protein of DNA poly-
merase J." 
 While this PCNA staining technique is theoretically 
designed for the identification of proliferating cells, weakly 
positive cells were also regarded as positive cells in the 
present investigation. The rationale is that since the PCNA 
protein is relatively stable, it probably stays for many hours 
in the nucleus and that, though at low levels, it is present in 
G2 and M phase as well. Therefore, in the present study, 
PCNA-positive cells were regarded as cells of proliferating 
phase,'," and in the sequential staining technique, PCNA 
was used only as a means for classifying cells into prolif-
erating and non-proliferating phase. 
 As the established theory employing AgNORs single 
staining for malignancy assessment, we know of the report 
of Crocker et al in 1987 which describes that in non-
Hodgkin's lymphoma the AgNORs count showed a signif-
icant difference between low-grade lymphoma and high-
grade lymphoma." However, it has also been reported that 
in solid tumors such as colorectal carcinoma and breast 
carcinoma, AgNORs single staining alone does not provide 
differentiation with statistical significance in pathological 
factors and cannot be a self-contained prognostic factor.8,9'
Table 7. Relationship between clinicopathologic factors and the ratio of AgNORs area per unclear area
                         A B C 
        PS- 11.46 ± 1.61 9.50 ± 2.01 6.16 ± 1.50
      PS+ 13.55 ± 2.15 1 X 11.86 ± 2.09 1 X 7.02 ± 1.44 1 NS 
     stage 1 II 11.60 ± 1.86 9.82 ± 2.40 6.27 ± 1.57 
     stage 1I N 13.51 ± 2.14 NS 11.78 ± 2.09 NS 6.99 ± 1.44 NS 
    size < 7.2cm 12.48 ± 1.83 NS 11.35 ± 2.31 1 NS 6.76 ± 1.07 NS 
    size > 7.2cm 13.70 ± 2.38 11.42 ± 2.29- 6.93 ± 1.78 
       n (-) 11.72 ± 1.69 10.56 ± 2.41 6.16.± 1.30 
      n(+) 13.73±2.14~XX 11.74±2.15]NS 7.15±1.46~NS 
        H- 13.02±2.12 11.33 ± 2.25 6.45 ± 1.01 
       H + 13.67 ± 2.78 NS 11.64 ± 2.52 1 NS 8.85 ± 1.89 X 
    Diploid 12.83 ± 2.701 NS 10.91 ± 2.61 ] NS 6.68 ± 0.88 NS 
     Aneuploid 13.20 ± 1.96 11.62 ± 2.09 6.93 ± 1.70 
A: PCNA positive cells X P < 0.01 
B: AgNORs single stained cells i X P < 0.05 
C: PCNA negative cells
Therefore, efforts are being made to develop an accurate 
yardstick of malignancy by using a variety of growth-
related markers in combination. For example, Kakeji et al 
reported that a combination of AgNORs and Ki-67 in 
gastric carcinoma provided a prediction of lymph node 
metastasis."' However, this is not an assessment made on 
the same cell. 
  As to the simultaneous assessment in the same section 
by AgNOR-Ki-67 sequential staining, Murray suggested its 
feasibility in 1989."' Then Janmohamed et al practiced the 
technique in non-Hodgkin's lymphomas in 1990 and re-
ported that the mean AgNORs count of Ki-67-positive cells 
was significantly higher than that of Ki-67-nepative cells."' 
In 1993 F. G. Smith et al reported about correlation be-
tween PCNA and AgNOR scores in non-Hodgkin's lym-
phomas using sequential staining technique."' In this paper, 
they reported, altough we have shown an association be-
tween PCNA labelling and AgNOR counts in NHL and 
therefore, yet again, an association between cell prolif-
eration and AgNOR scores, it appears that PCNA negative 
cells still have relatively high counts in lymphomas. As for 
the solid tumor, in 1993, Yoshida et al established a 
PCNA-AgNORs sequential staining technique using col-
orectal carcinoma cells."' However, their paper is primarily 
devoted to fundamental studies on the staining method and 
considers little about correlation of data with clinicopa-
thological factors. Under the circumstances, the present 
author used this technique in gastric carcinoma and evalu-
ated the data in correlation with clinicopathological factors 
for the first time. As a result, the mean AgNORs count of 
the sequential stain-positive cells showed a statistical dif-
ference at a lower P value of significance between stage I + 
II and stage III + IV. Moreover, only sequential stain-
positive cells showed significant differences in lymph node 
mtastasis, depth of invasion and size. 
  In PCNA- negative cells, a significant difference was 
found in the incidence of liver metastasis. These findings 
could not be generated by the standard AgNORs single 
staining technique and the information provided by this 
sequential staining technique seems to have the potential of 
being a self-contained prognostic factor. 
 To resolve the indefiniteness of data interpretation, an 
image analyzer which permits an objective size assessment 
of AgNORs was additionally employed in the present 
study. 
  Regarding the image analyzer, Derenzini et al report that 
in epithelial tumor of the colon, the carcinoma cells are 
greater in mean AgNORs count per nucleus and smaller in 
size than adenoma and hyperplastic polyp."' However, 
there is no report on an investigation using gastric carci-
noma cells. In the present study, not only the number but 
also the sectional area of AgNORs in carcinoma cells 
showed the significant increase compared with normal 
cells. One finding of unusual interest was the ratio of 
AgNORs area per nuclea area in nonproliferating cells
showed a significant difference (P < 0.01) in liver metas-
tasis cases. While this is true with the mean AgNORs 
count, it is suspected that a liver metastasis case has a 
higher proliferation potential even in the cells of nonpro-
liferating phase. This is a new sort of information which 
cannot be obtained by single staining and may be the 
admonition that in cases liable to develop liver metastasis 
attention should be paid to mean AgNORs count and the 
ratio of AgNORs area pre nuclear area in nonproliferating 
phase. Should an exploration of this kind be extended to 
greater cohorts in future studies, we might even be able to 
establish a critical value. 
 The question to be addressed to in the future for the sake 
of this sequential staining technique as applied to gastric 
carcinoma is concerned with the evaluation of signet ring 
cell carcinoma. This cell has a significantly low labelling 
index with PCNA. Although only 3 relevant specimens 
could be studied in the present investigation, their PCNA 
labelling index was 10.2% versus 46.3% for the total 
population. In this connection, it might be the case that as 
the very nucleus of the cell is fairly small, the accumulation 
of PCNA is also proportionally small and, therfore, we 
have to deal with this type of cell separately as a special 
one. 
  It is, thus, clear from the above results that in order to 
evaluate the degree of malignancy of tumors from their 
proliferation potential, the standard AgNORs single stain-
ing method is inadequate and that with attention paid to 
nonproliferating cells, no to speak of proliferating cells, as 
many parameters of intracellular information as possible 
should be unearthed from the same cell by a sequential 
staining technique such as this. Actually in the present 
study, useful information was obtained on gastric carci-
noma cells in both proliferating and nonproliferating 
phases and this suggests that the described sequential 
staining technique is a recommendable procedure.
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